Hygenica is a global leader within the field of Hospital Infection Prevention and Control, and we are committed to improving standards of patient care. Our goal is to ensure that our innovative antimicrobial Fantex® HAI Prevention technology is appropriately adopted in clinical practice throughout the world, to better protect patients from unnecessarily contracting potentially fatal Hospital Acquired Infections (HAIs).
Contaminated hospital surfaces are a widely recognised source of infection and modern infection control programmes must utilise every innovation available to effectively sanitise the hospital environment to protect patients from HAIs. When integrated across hospital hard and soft surfaces, Fantex® HAI Prevention technology is scientifically proven to rapidly reduce pathogenic load – substantially decreasing the transmission risk emanating from cross-contamination at high-frequency touchpoint surfaces.
Patient privacy curtains are one of the most frequently touched surfaces in the near-patient environment and are a well-known source of infection. Disposable Fantex® HAI Prevention Curtains offer best-in-class, rapid antimicrobial efficacy against a broad spectrum of harmful pathogens. Following rigorous independent testing which demonstrated an unparalleled 99.9% (Log3) kill rate in under one minute, they were first approved for use in Europe in 2008. Currently recognised as the most hygienic curtains, they have since been adopted by the world’s leading teaching hospitals and centres of excellence.
Similarly, Fantex® Hard Surface Cleaner and Fantex® Sanitising Fabric Spray are unique disinfection agents which deliver outstanding 24-hour Log5 (99.999%) protection.
When integrated within hospital-wide infection control programmes, cost-effective Fantex® HAI Prevention technology can help to improve patient safety, reduce healthcare resource utilisation and conserve an increasingly precious antibiotic treatment arsenal.
